Episode 128. Ensifentrine (Ohtuvayre) for COPD: 2024 FDA Approval, ENHANCE Trials, and What You Need to Know

Roger Seheult, MD of MedCram explains a new FDA approved medication for COPD and the ENHANCE trials. See all Dr. Seheult's videos at: (This video was recorded on April 28th, 2025) Roger Seheult, MD is the co-founder and lead professor at He is Board Certified in Internal Medicine, Pulmonary Disease, Critical Care, and Sleep Medicine and an Associate Professor at the University of California, Riverside School of Medicine. MEDCRAM WORKS WITH MEDICAL PROGRAMS AND HOSPITALS: MedCram offers group discounts for students and medical programs, hospitals, and other institutions. Contact us at customers@medcram.com if you are interested. MEDIA CONTACT: Media Contact: customers@medcram.com Media contact info: Video Produced by Kyle Allred

You can listen to Episode 128. Ensifentrine (Ohtuvayre) for COPD: 2024 FDA Approval, ENHANCE Trials, and What You Need to Know online on Radio and Podcast. Open the player on this page to stream the available audio.

Episode 128. Ensifentrine (Ohtuvayre) for COPD: 2024 FDA Approval, ENHANCE Trials, and What You Need to Know is an episode from MedCram by Kyle Allred.

This episode is 12:46 long.

This episode was published on May 1, 2025.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from MedCram when more episodes are available from the podcast feed.